Liver Cancer

November 11, 2021
The 2025 Strategic Plan outlines goals, strategic approaches, objectives, and outcome measures for making measurable progress in reducing new viral hepatitis infections and viral hepatitis-associated illnesses, deaths, and disparities in the United States over the next five years. 
November 10, 2021
This report augments (i.e., updates and summarizes) previously published recommendations from CDC regarding testing for HCV infection in the United States (Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during…
October 6, 2021
To help improve policy makers and cancer control professionals’ awareness of viral hepatitis risk factors and evidence-based prevention strategies, The George Washington University Cancer Center, in collaboration with CDC, developed educational materials on viral hepatitis and liver cancer. By…
September 30, 2021
he National Viral Hepatitis Progress Report provides information on progress in the implementation of recommended interventions and the impact these interventions are having on prevention of viral hepatitis transmission, disease, and associated mortality.
September 28, 2021
Here are some essential interventions public health professionals can implement that will address the burden of viral hepatitis, as presented in the National Academies of Sciences, Engineering and Medicine’s “A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report.”
January 1, 2021
The Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021-2025 (Viral Hepatitis Plan or Plan), released on January 7, 2021, is a new phase in the fight against viral hepatitis in the United States.
January 1, 2011
This tip sheet provides ways to help organize a successful hepatitis B screening event in your community.